4D Molecular Therapeutics Presents Interim Results from the
4D-125 was well tolerated in all patients treated to-date (n=8), with no dose-limiting toxicities, no serious adverse events and no chronic...
Source: globenewswire.com
Stay updated with breaking news from Clinical Data Summary. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
4D-125 was well tolerated in all patients treated to-date (n=8), with no dose-limiting toxicities, no serious adverse events and no chronic...